Company patents
I-PEX Inc.
I-PEX Inc. demonstrates a strong, albeit consolidating, focus on Electrical Connectors, which constitutes 74.6% of its patent portfolio, despite a -11.1% decline in 2025 and a significant drop so far in 2026. Surprisingly, while Material & Chemical Analysis saw a substantial 150.0% growth in 2025, indicating an emerging focus, the company's patenting activity across most categories, including this one, has seen a sharp decline so far in 2026, suggesting a potential shift in R&D priorities or a temporary slowdown in filings.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
67 US filings (since 2023) · 6 categories · 7 themes
Connectors specifically designed for high current or voltage applications, often incorporating features for power delivery, thermal management, or combining power and signal lines.
Design of contact elements and their interaction to ensure stable, low-resistance electrical connection under various mechanical and environmental conditions, including spring forces and material choices.
Systems and methods for preparing, organizing, and electrically connecting individual conductors or cable bundles to connector terminals, ensuring reliable contact and strain relief.
Mechanical features or components integrated into connector housings or mating interfaces to ensure secure engagement and prevent accidental disengagement.
Structural design and manufacturing techniques for bundling multiple wires into harnesses, including protective layers like braiding and interlocking armor, and methods for assembly and termination.
Design techniques and components within connectors to minimize signal degradation, crosstalk, and impedance mismatches for high-frequency data transmission.
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Patents
Showing 1-10 of 93